Patents by Inventor Trevor Barrowcliffe

Trevor Barrowcliffe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising coagulation factors IXA and VIII for the treatment of haemophilia A or B
    Patent number: 7977460
    Abstract: The present invention relates to the use of FIXa and FVIII in the preparation of a composition for the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies. The present invention further relates to a composition comprising FIXa and a composition comprising FVIII for simultaneous, simultaneous separate or sequential use in the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: July 12, 2011
    Assignee: National Institute for Biological Standards and Control
    Inventor: Trevor Barrowcliffe
  • Composition
    Publication number: 20040235737
    Abstract: The present invention relates to the use of FIXa and FVIII in the preparation of a composition for the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies. The present invention further relates to a composition comprising FIXa and a composition comprising FVIII for simultaneous, simultaneous separate or sequential use in the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies.
    Type: Application
    Filed: April 21, 2004
    Publication date: November 25, 2004
    Inventor: Trevor Barrowcliffe